Interestingly, both HOP and SYNPO2 have been implicated as tumor suppressor genes, HOP in female choriocarcinomas associated with hydatiform moles and esophageal tumors, and SYNPO2 in bladder and prostate cancer [23, 24]. This evidence concerns the gene SYNPO2 and Familial prostate cancer.